MARC details
| 000 -LEADER |
|---|
| fixed length control field |
09280cam a2200373 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
52639325 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190211151006.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
030129s2003 stka b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0443071454 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780443071454 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0443072027 (International ed.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780443072024 (International ed.) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)52639325 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
NLM |
| Language of cataloging |
eng |
| Transcribing agency |
YUS |
| 040 ## - CATALOGING SOURCE |
|---|
| Modifying agency |
NLM |
| -- |
JDR |
| -- |
IXA |
| -- |
BAKER |
| -- |
NLGGC |
| -- |
YDXCP |
| -- |
CGC |
| -- |
UQ1 |
| -- |
AU@ |
| -- |
U9S |
| -- |
OCLCQ |
| -- |
ERN |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
ERNA |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM300 |
| Item number |
.P577 2003 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
615.1 RAN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Pharmacology / |
| Statement of responsibility, etc. |
H.P. Rang ... [et al.] ; illustrations by Peter Lamb. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
5th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Edinburgh ; |
| -- |
New York : |
| Name of publisher, distributor, etc. |
Churchill Livingstone, |
| Date of publication, distribution, etc. |
2003. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xii, 797 p. : |
| Other physical details |
ill. (some coloured) |
| Dimensions |
28 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Title |
General principles |
| -- |
1.What is pharmacology |
| -- |
2.How drugs act: general principles |
| -- |
3.How drugs act: general principles |
| -- |
4.Cellular mechanisms: excitation, contraction and secretion |
| -- |
5.Cellular mechanism: cell proliferation and apoptosis |
| -- |
6.Method and measurement in pharmacology |
| -- |
7.Absorption and distribution of drugs |
| -- |
8.Drug elimination and pharmcokinetics |
| -- |
Chemical mediators |
| -- |
9.Chemical mediatiors and the autonomic nervous system |
| -- |
10.Cholinergic transmission |
| -- |
11.Noradgrenergic transmission |
| -- |
12.Other poeripheral mediators: 5-hydrozytryptamine and purines |
| -- |
13.Peptides and proteins as mediators |
| -- |
14.Nitric oxide |
| -- |
15.Local hormones, inflamation and immune reactions |
| -- |
16.Anti-inflammatory and immunosuppressant drugs |
| -- |
Drugs affecting major organ systems |
| -- |
17.The heart |
| -- |
18.The vascular system |
| -- |
19.Atherosclerosis and lipoprotein metabolism |
| -- |
20.Haemostasis and thrombosis |
| -- |
21.The haemopoietic system |
| -- |
22.The respiratory system |
| -- |
23.The kidney |
| -- |
24.The gastrointestinal tract |
| -- |
25.The endocrine pancreas and the control of blood glucose |
| -- |
26.Obesity |
| -- |
27.The piturity and adrenal cortex |
| -- |
28.The thyroid |
| -- |
29.The reproductive system |
| -- |
30.Bone metabolism |
| -- |
The nervous system |
| -- |
31.Chemical transmission and drug action in the central nervous system |
| -- |
32.Amino acid transmitters |
| -- |
33.Other transmitters and modulators |
| -- |
34.Neurodegenerative disorders |
| -- |
35.General anaesthetic agents |
| -- |
36.Anxialytic and hypnotic drugs |
| -- |
37.Antipsychotic drugs |
| -- |
38.Drugs used in affective disorders |
| -- |
39.Antiepileptic drugs |
| -- |
40.Analgesic drugs |
| -- |
41.CNS stimulants and psychotomimetic drugs |
| -- |
42.Drug dependence and drug abuse |
| -- |
43.Local anaesthetics |
| -- |
Drugs used in the treatment of infections and cancer |
| -- |
44.Basic principles of chemotherapy |
| -- |
45.Antibacterial drugs |
| -- |
46.Antiviral drugs |
| -- |
47.Antifungal drugs |
| -- |
48.Antiprotozoal drugs |
| -- |
49.Anthelminthic drugs |
| -- |
50.Cancer chemotherapy |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| 9 (RLIN) |
402 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chemotherapy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Rang, H. P. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |